Opexa Therapeutics Inc (NASDAQ: OPXA) shares rose 15.6% to 44 cents. On Tuesday, Maxim Group initiated coverage on Opexa Therapeutics with a buy rating and a $5.00 price target. Share volume was over one million, compared to an all-day average of 119,000
